Back to Search
NATHAN LA MONICA, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1558709204Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
10031(TN)
Research & Publications (20)
Antiapoptotic small interfering RNA as potent adjuvant of DNA vaccination in a mouse mammary tumor model.
PMID 19222350·Hum Gene Ther·2009
7-preclinical
ErbB2 genetic cancer vaccine in nonhuman primates: relevance of single nucleotide polymorphisms.
PMID 19257854·Hum Gene Ther·2009
7-preclinical
Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.
PMID 19464068·J Hepatol·2009
7-preclinical
A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines.
PMID 19162112·Vaccine·2009
7-preclinical
MMP11: a novel target antigen for cancer immunotherapy.
PMID 19509157·Clin Cancer Res·2009
7-preclinical
Treatment of mammary carcinomas in HER-2 transgenic mice through combination of genetic vaccine and an agonist of Toll-like receptor 9.
PMID 19240169·Clin Cancer Res·2009
7-preclinical
Coadministration of telomerase genetic vaccine and a novel TLR9 agonist in nonhuman primates.
PMID 19623161·Mol Ther·2009
7-preclinical
Comparative expression pathway analysis of human and canine mammary tumors.
PMID 19327144·BMC Genomics·2009
4-observational
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
PMID 19561534·J Immunother·2009
7-preclinical
An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models.
PMID 18989354·Cancer Gene Ther·2009
7-preclinical
A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas.
PMID 18937552·Hum Gene Ther·2009
7-preclinical
Gene therapy of Hunter syndrome: evaluation of the efficiency of muscle electro gene transfer for the production and release of recombinant iduronate-2-sulfatase (IDS).
PMID 18675343·Biochim Biophys Acta·2008
7-preclinical
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
PMID 19047167·Cancer Res·2008
7-preclinical
Therapeutic vaccination halts disease progression in BALB-neuT mice: the amplitude of elicited immune response is predictive of vaccine efficacy.
PMID 18533895·Hum Gene Ther·2008
7-preclinical
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
PMID 17998148·J Hepatol·2008
7-preclinical
Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
PMID 17662890·Exp Hematol·2007
7-preclinical
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge.
PMID 17053815·Cancer Gene Ther·2007
7-preclinical
Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates.
PMID 17304509·Int J Cancer·2007
7-preclinical
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects.
PMID 18055074·Vaccine·2007
7-preclinical
Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokines.
PMID 17010367·J Immunol Methods·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3001 KNOXVILLE CENTER DR, SUITE 1100
KNOXVILLE, TN 37924 - Phone
- (865) 544-1711
Quick Facts
- NPI
- 1558709204
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile